Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $88.1B
1-Year Est. Return 25.21%
This Quarter Est. Return
1 Year Est. Return
+25.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$78.5B
AUM Growth
+$5.7B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,023
New
Increased
Reduced
Closed

Top Buys

1 +$159M
2 +$133M
3 +$92.1M
4
ACN icon
Accenture
ACN
+$70.2M
5
SRE icon
Sempra
SRE
+$69.7M

Top Sells

1 +$94M
2 +$83.5M
3 +$81.4M
4
AVB icon
AvalonBay Communities
AVB
+$78.4M
5
LLY icon
Eli Lilly
LLY
+$76.3M

Sector Composition

1 Technology 28.17%
2 Financials 13.64%
3 Consumer Discretionary 10.42%
4 Healthcare 9.23%
5 Communication Services 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENFN
3751
DELISTED
Enfusion, Inc.
ENFN
-163
EQC
3752
DELISTED
Equity Commonwealth
EQC
-148,160
PDCO
3753
DELISTED
Patterson Companies, Inc.
PDCO
-54,699
AMPS
3754
DELISTED
Altus Power
AMPS
-55
PYCR
3755
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
-794
ATSG
3756
DELISTED
Air Transport Services Group
ATSG
-19,168
ACCD
3757
DELISTED
Accolade Inc
ACCD
-926
LGTY
3758
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
-402,532
NVRO
3759
DELISTED
NEVRO CORP.
NVRO
-149
SASR
3760
DELISTED
Sandy Spring Bancorp Inc
SASR
-30
FBMS
3761
DELISTED
The First Bancshares, Inc.
FBMS
-37,648
ML
3762
DELISTED
MoneyLion Inc.
ML
-403
SWI
3763
DELISTED
SolarWinds Corporation Common Stock
SWI
-266
DESP
3764
DELISTED
Despegar.com
DESP
-264,214
DFAT icon
3765
Dimensional US Targeted Value ETF
DFAT
$11.4B
-180
DFS
3766
DELISTED
Discover Financial Services
DFS
-193,757
DH icon
3767
Definitive Healthcare
DH
$281M
-106
DOUG icon
3768
Douglas Elliman
DOUG
$222M
-4,808
DRD
3769
DRDGold
DRD
$2.42B
-21,203
DXLG icon
3770
Destination XL Group
DXLG
$51.9M
-106
ECVT icon
3771
Ecovyst
ECVT
$979M
-293
EDV icon
3772
Vanguard World Funds Extended Duration ETF
EDV
$3.92B
-68
EP icon
3773
Empire Petroleum
EP
$105M
-27
ETWO
3774
DELISTED
E2open Parent Holdings
ETWO
-19,671
EYPT icon
3775
EyePoint Pharmaceuticals
EYPT
$953M
-1,149